期刊文献+

抗肿瘤药物信号转导通路的研究进展 被引量:1

Research Progress of the Signal Transduction Pathways of Antitumor Drugs
下载PDF
导出
摘要 细胞信号转导通路在肿瘤的发生、发展中发挥着重要作用。近年来,人们逐渐认识到肿瘤发生的本质是细胞信号转导通路异常所致。一系列针对肿瘤细胞内信号转导通路中关键分子的靶向性抗肿瘤药物的研发成为现阶段抗肿瘤药物研发的焦点,这可能在癌症治疗领域取得突破性和革命性进展。现着重介绍几类在细胞信号转导通路方面研究较成熟的抗肿瘤药物。 Cell signal transduction pathway plays a vital role in tumor development. In recent years, peo- ple gradually realize that the nature of tumor is caused by the abnormal cell signal transduction pathway. So, a series of studies on antitumor drugs targeted at the key elements are becoming the focus ,which may be the breakthrough and revolutionary progress in the field of cancer treatment. Here is to introduce several kinds of antitumor drugs,the pathways of which are relatively well studied.
作者 李俊 王剑松
出处 《医学综述》 2012年第17期2796-2799,共4页 Medical Recapitulate
关键词 抗肿瘤药物 信号转导 通路 Antitumor drugs Signal transduction Pathways
  • 相关文献

参考文献21

  • 1Vignot S, Soria JC, Spano JP, et al. Protein kinases C:a new cyto- plasmic target [ J ]. Bull Cancer,2008,95 ( 7 ) : 683-689.
  • 2贺松其,姚飞龙,吕志平,程旸,李嘉璐.Wnt/β-catenin信号通路在肝癌转移侵袭中的调控机制[J].中国实验方剂学杂志,2011,17(7):251-254. 被引量:24
  • 3郭琳,王强.PI3K/Akt/mTOR信号传导通路与恶性肿瘤浸润和转移的研究进展[J].现代肿瘤医学,2009,17(8):1585-1589. 被引量:24
  • 4Banerjee MS, Chakraborty PK, Raha S. Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) ceultslls res in the downregulation of Hsp70 [ J]. PLoS One,2010,5 ( 1 ) :e8719-e8720.
  • 5Cirstea D, Hideshima T, Rodig S, et al. Dual inhibition of akt/ mammalian target of rapamycin pathway by nanoparticle albumin- bound-rapamycin and perifosine induces antitumor activity in mul- tiole mvelomal-J]. Mol Cancer Ther.2010.9(4) :963-975.
  • 6Lu J, Wu DM, Zheng YL, et al. Purple sweet potato color alleviates D-galactose-induced brain aging in old mice by promoting survival of neurons via PI3 K pathway and inhibiting cytochrome C-mediated apoptosis [ J]. Brain Patho1,2010,20( 3 ) :598-612.
  • 7Ramos-Nino ME, Littenberg B. A novel combination: ranpirnase and rosiglitazone induce a synergistic apoptotic effect by down-reg- ulating Fra-1 and survivin in cancer cells [ J ]. Mol Cancer Ther, 2008,7(7) :1871-1879.
  • 8nudes GR Targeting mTOR in renal cell carcinoma [J]. Cancer,2009,115 ( 10 Suppl) :2313-2320.
  • 9Blay JY. Updating progress in sarcoma therapy with roTOR inhibi- tors[ J ]. Ann Oncol,2011,22 (2) :280-287.
  • 10Mason WP, MacNeil M, Easaw J, et al. A phase I study of temozo- lomide ( TMZ ) and RAD001 in patients (pts) with glioblastoma mul- tiforme(GBM) [ J]. J Clin Oncol,2009,27( 15 Suppl) :2036.

二级参考文献47

共引文献50

同被引文献6

  • 1Engelberth SA, Hempel N, Bergkvist M, et al. Development of nanoscale approaches for ovarian cancer therapeutics and di- agnostics [J]. Crit Rev Oncog, 2014, 19 (3-4): 281- 315.
  • 2Chene G, Lamblin G, Le Bail-Carval K, et al. Early prcin- vasive lesions in ovarian cancer [J]. Biomed Res lnt, 2014, 2014: 639252.
  • 3Patel RA, Forinash KD, Pireddu R, et al. RKI-1447 is a potent inhibitor of the Rho- associated ROCK kinases ~ith anti-invasive and anti-tumor activities in breast cancer [J]. Cancer Res, 2012, 72 (19) : 5025 - 5034.
  • 4Rath N, Olson MF. Rho-associaled kinases in tumorigens s: re-considering ROCK inhibition for cancer therapy [J]. EM BO Rep, 2013, 13 (10) : 900-908.
  • 5牛凤兰,董卿,巩宏伟,哈卿,孙文怡.菱角粗多糖对肿瘤细胞抑制作用[J].中国公共卫生,2009,25(8):1005-1006. 被引量:16
  • 6郁玲玲,顾建英.Rho亚家族在肿瘤侵袭中的作用研究进展[J].复旦学报(医学版),2010,37(5):617-619. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部